Now Reading: RML recalls 10 drug batches over quality failures and defects
-
01
RML recalls 10 drug batches over quality failures and defects
Dr Ram Manohar Lohia Hospital in New Delhi has recalled 10 batches of medicines after they were found to be ‘Not of Standard Quality’ or had physical defects. The affected drugs include sodium valproate, spironolactone, imipramine, metoprolol, and methyl ergometrine, used to treat seizures, heart conditions, depression and postpartum bleeding.
Four notices issued between 7 and 14 September directed departments to stop using the batches and return them. Three tablet batches and five injectable batches failed analytical testing, while two tablet batches, isosorbide mononitrate and metoprolol, were found in powder form inside the strip. The defective tablets were made by Glowson India Labs Pvt Ltd.
The hospital said no severe adverse effects had been reported so far. Alternative medicines have been arranged to avoid disruption in patient care.
Indian Opinion Analysis
The recall covers widely used drugs across multiple clinical departments, meaning disruption could affect many patients if alternatives are not smoothly supplied. RML says no severe adverse effects have been reported, but the notices were issued in early September, leaving a gap of weeks before public disclosure. The next step is whether the drug suppliers face regulatory action and whether other central-government hospitals supplied by the same manufacturers will also review their stocks.
Source: timesofindia.indiatimes.com
This brief was synthesised by AI from the source linked above. Methodology and corrections.
